HIGHLIGHTS
- who: Yiping Wei and Wenxiong Zhang from the Nottingham University Hospitals NHS Trust, United Kingdom have published the research: Efficacy and safety of netarsudil/latanoprost fixed-dose combination vs. monotherapy in open-angle glaucoma or ocular hypertension: A systematic review and meta-analysis of randomized controlled trials, in the Journal: (JOURNAL)
- how: The authors conducted a meta-analysis of related randomized controlled trial studies (RCTs) to compare the IOP-lowering efficacy and safety of netarsudil/latanoprost FDC with its individual components for treating patients with OAG or OHT. The detailed search results are shown in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.